The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives.

cross-kingdom interactions fungal pathogenesis microbiome mycobiome next-generation sequencing

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
13 Apr 2022
Historique:
received: 01 03 2022
revised: 04 04 2022
accepted: 09 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 24 4 2022
Statut: epublish

Résumé

Microbes play an important role in the pathogenesis of chronic lung diseases, such as chronic obstructive pulmonary disease, cystic fibrosis, non-cystic fibrosis bronchiectasis, and asthma. While the role of bacterial pathogens has been extensively studied, the contribution of fungal species to the pathogenesis of chronic lung diseases is much less understood. The recent introduction of next-generation sequencing techniques has revealed the existence of complex microbial lung communities in healthy individuals and patients with chronic respiratory disorders, with fungi being an important part of these communities' structure (mycobiome). There is growing evidence that the components of the lung mycobiome influence the clinical course of chronic respiratory diseases, not only by direct pathogenesis but also by interacting with bacterial species and with the host's physiology. In this article, we review the current knowledge on the role of fungi in chronic respiratory diseases, which was obtained by conventional culture and next-generation sequencing, highlighting the limitations of both techniques and exploring future research areas.

Identifiants

pubmed: 35456861
pii: microorganisms10040810
doi: 10.3390/microorganisms10040810
pmc: PMC9029612
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI17/00115
Organisme : Instituto de Salud Carlos III
ID : PI19/01043
Organisme : Instituto de Salud Carlos III
ID : JR18/00034
Organisme : Instituto de Salud Carlos III
ID : CM19/00069
Organisme : Instituto de Salud Carlos III
ID : RD16/0016/0011
Organisme : Instituto de Salud Carlos III
ID : CB21/13/00084

Références

J Allergy Clin Immunol. 2015 Jan;135(1):110-22
pubmed: 25159468
Med Mycol. 2018 Apr 1;56(suppl_1):102-125
pubmed: 29538735
Clin Microbiol Infect. 2010 Jul;16(7):870-7
pubmed: 19906275
Med Mycol. 2014 Feb;52(2):179-86
pubmed: 23651180
Microb Pathog. 2019 Apr;129:168-175
pubmed: 30742949
Int J Mol Sci. 2018 Jan 04;19(1):
pubmed: 29300314
J Fungi (Basel). 2020 Jun 09;6(2):
pubmed: 32526938
Science. 2020 Feb 21;367(6480):
pubmed: 32079744
PLoS Pathog. 2016 Sep 08;12(9):e1005858
pubmed: 27607188
Arch Bronconeumol (Engl Ed). 2020 May;56(5):282-290
pubmed: 31784349
J Clin Pathol. 1999 May;52(5):385-7
pubmed: 10560362
Eur Respir J. 2020 Aug 27;56(2):
pubmed: 32341102
Nat Med. 2021 Nov;27(11):1885-1892
pubmed: 34789871
Microbiome. 2017 Nov 25;5(1):153
pubmed: 29178920
Front Microbiol. 2015 Feb 13;6:89
pubmed: 25762987
Chest. 2010 Nov;138(5):1186-95
pubmed: 20472859
J Cyst Fibros. 2019 Mar;18(2):212-220
pubmed: 30348610
Am J Respir Crit Care Med. 2010 Sep 1;182(5):627-32
pubmed: 20463179
Med Mycol. 2020 Sep 14;:
pubmed: 32926151
BMC Pulm Med. 2018 May 22;18(1):83
pubmed: 29788932
J Cyst Fibros. 2021 Mar;20(2):295-302
pubmed: 32540174
Front Microbiol. 2019 Mar 15;10:512
pubmed: 30930884
Am J Respir Cell Mol Biol. 2013 Feb;48(2):150-6
pubmed: 23103995
Front Microbiol. 2017 Jul 31;8:1432
pubmed: 28824566
BMC Genomics. 2019 Jun 15;20(1):496
pubmed: 31202277
Mycopathologia. 2020 Apr;185(2):207-231
pubmed: 31894501
J Clin Microbiol. 2015 Sep;53(9):2900-7
pubmed: 26135861
J Cyst Fibros. 2010 Mar;9(2):110-6
pubmed: 20045384
Respir Res. 2014 Feb 11;15:17
pubmed: 24517318
Clin Microbiol Infect. 2011 Sep;17(9):1381-6
pubmed: 21087348
Am J Respir Crit Care Med. 2015 Apr 15;191(8):932-42
pubmed: 25603113
Arch Bronconeumol. 2017 Jul;53(7):366-374
pubmed: 28118936
Am J Respir Crit Care Med. 2021 May 1;203(9):1099-1111
pubmed: 33166473
Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1513-8
pubmed: 7952609
Sci Rep. 2020 Feb 27;10(1):3589
pubmed: 32108159
J Allergy Clin Immunol. 2018 Aug;142(2):407-414
pubmed: 29122659
Nat Med. 2014 Jun;20(6):642-7
pubmed: 24813249
Med Mycol. 2010 Feb;48(1):56-63
pubmed: 19184771
PLoS Pathog. 2010 Jan 08;6(1):e1000713
pubmed: 20072605
Clin Exp Allergy. 2015 Dec;45(12):1765-78
pubmed: 26177981
Nat Commun. 2017 Nov 15;8(1):1512
pubmed: 29142211
Eur Respir J. 2021 Mar 11;57(3):
pubmed: 32972986
Front Microbiol. 2018 Jun 05;9:1205
pubmed: 29922270
Mycopathologia. 2014 Dec;178(5-6):457-63
pubmed: 25151366
PLoS One. 2012;7(4):e36313
pubmed: 22558432
Int J Chron Obstruct Pulmon Dis. 2017 May 11;12:1401-1411
pubmed: 28546748
Microbiome. 2013 Feb 04;1(1):6
pubmed: 24451270
Front Microbiol. 2017 Dec 12;8:2477
pubmed: 29312187
Respir Med. 2007 Nov;101(11):2248-53
pubmed: 17698334
Clin Transl Allergy. 2020 Oct 22;10:42
pubmed: 33110490
Sci Rep. 2019 Feb 6;9(1):1531
pubmed: 30728424
Allergy Asthma Proc. 2016 May;37(3):41-6
pubmed: 27178886
Med Mycol. 2012 May;50(4):433-8
pubmed: 21961802
Arch Bronconeumol. 2017 Sep;53(9):473-474
pubmed: 28069293
Sci Rep. 2019 Jun 27;9(1):9328
pubmed: 31249384
Eur Respir J. 2018 Jul 27;52(1):
pubmed: 29880655
Sci Rep. 2020 Nov 4;10(1):18999
pubmed: 33149181
Mycopathologia. 2018 Feb;183(1):119-137
pubmed: 28770417
Mol Ecol Resour. 2020 Jan;20(1):170-184
pubmed: 31599091
Respir Med. 1999 Nov;93(11):835-8
pubmed: 10603634
Pediatr Pulmonol. 2015 Nov;50(11):1082-9
pubmed: 26383963
J Fungi (Basel). 2020 Dec 21;6(4):
pubmed: 33371198
BMC Pulm Med. 2020 Sep 11;20(1):241
pubmed: 32912168
Am J Respir Crit Care Med. 2020 Mar 15;201(6):688-696
pubmed: 31747309
Nat Microbiol. 2016 Apr 04;1:16031
pubmed: 27572644
PLoS One. 2017 Jan 18;12(1):e0169877
pubmed: 28099455
Respiration. 2015;89(5):396-403
pubmed: 25924628
Arch Bronconeumol (Engl Ed). 2020 Jun 30;:
pubmed: 32620417
Front Cell Infect Microbiol. 2020 Nov 26;10:583418
pubmed: 33324573
BMC Infect Dis. 2013 Feb 05;13:69
pubmed: 23384395
J Cyst Fibros. 2019 Mar;18(2):221-226
pubmed: 30514613
Ann Am Thorac Soc. 2016 Sep;13(9):1468-75
pubmed: 27348199
Cell Host Microbe. 2016 Jun 8;19(6):865-73
pubmed: 27237365
Curr Opin Pulm Med. 2022 Mar 1;28(2):121-133
pubmed: 34839338
Eur J Immunol. 2014 Nov;44(11):3156-65
pubmed: 25256637
PLoS One. 2016 Dec 28;11(12):e0168860
pubmed: 28030619
Arch Bronconeumol (Engl Ed). 2019 Apr;55(4):187-188
pubmed: 30470557
Med Mycol. 2009;47 Suppl 1:S183-91
pubmed: 18651306
Microbiome. 2014 Nov 03;2:40
pubmed: 25408892
Am J Respir Crit Care Med. 2012 Sep 15;186(6):536-45
pubmed: 22798321
Cell Host Microbe. 2014 Jan 15;15(1):95-102
pubmed: 24439901
Front Microbiol. 2016 Oct 17;7:1629
pubmed: 27799926
Chest. 2013 May;143(5):1351-1357
pubmed: 23139075
Am J Respir Crit Care Med. 2011 Jul 15;184(2):198-205
pubmed: 21471101
Eur Respir J. 2020 Aug 27;56(2):
pubmed: 32855304
Chest. 2010 Jan;137(1):171-6
pubmed: 19567494
Sci Data. 2020 Jul 13;7(1):228
pubmed: 32661237
Arch Bronconeumol (Engl Ed). 2018 Feb;54(2):88-98
pubmed: 29128129
Nat Rev Microbiol. 2019 Jan;17(2):95-109
pubmed: 30442909
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6241-6
pubmed: 22454494
Pediatr Pulmonol. 1996 Jan;21(1):6-10
pubmed: 8776259
PLoS One. 2018 Feb 14;13(2):e0192898
pubmed: 29444186
Arch Bronconeumol (Engl Ed). 2021 Jan;57(1):61-69
pubmed: 32950310
Int Arch Allergy Immunol. 2011;155(2):95-105
pubmed: 21196753
Gastroenterology. 2021 Jan;160(1):272-286.e11
pubmed: 32956679
Int J Mol Sci. 2019 Oct 09;20(20):
pubmed: 31601001
Am J Respir Crit Care Med. 2019 Apr 1;199(7):842-853
pubmed: 30265843
Med Mycol. 2010 Nov;48(7):988-94
pubmed: 20370368
Arch Bronconeumol (Engl Ed). 2019 Apr;55(4):181-182
pubmed: 30314689
J Cyst Fibros. 2016 Sep;15(5):e45-9
pubmed: 26936234
Arch Bronconeumol (Engl Ed). 2020 Jan;56(1):1-2
pubmed: 30803838
Am J Respir Crit Care Med. 2019 May 15;199(10):1205-1213
pubmed: 30376356
Arch Bronconeumol (Engl Ed). 2021 Jan;57(1):28-35
pubmed: 32081438
Genome Med. 2013 Jul 30;5(7):63
pubmed: 23899327
N Engl J Med. 2015 Apr 16;372(16):1574-5
pubmed: 25875271
Appl Environ Microbiol. 2020 Jan 7;86(2):
pubmed: 31704678
Pharmaceutics. 2021 Nov 25;13(12):
pubmed: 34959290
Clin Microbiol Rev. 2010 Apr;23(2):299-323
pubmed: 20375354
Front Cell Infect Microbiol. 2020 Feb 19;10:9
pubmed: 32140452
Clin Respir J. 2021 Feb;15(2):123-133
pubmed: 33063421
Mycopathologia. 2018 Feb;183(1):7-19
pubmed: 29098487
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
J Clin Invest. 2021 Aug 2;131(15):
pubmed: 34338230
Arch Bronconeumol. 2008 Mar;44(3):146-51
pubmed: 18361886
Curr Opin Pulm Med. 2013 Nov;19(6):670-5
pubmed: 24060984
Pathogens. 2019 May 21;8(2):
pubmed: 31117285
BMC Pulm Med. 2013 Nov 01;13:61
pubmed: 24180379
Eur Respir J. 2014 Jan;43(1):64-71
pubmed: 23598955
J Allergy Clin Immunol. 2019 Nov;144(5):1214-1227.e7
pubmed: 31279011
J Allergy Clin Immunol. 1984 Jan;73(1 Pt 1):44-8
pubmed: 6693666
Pediatr Pulmonol. 2010 Aug;45(8):764-71
pubmed: 20597074
PLoS One. 2021 Apr 7;16(4):e0248967
pubmed: 33826639
Chest. 2002 Mar;121(3):782-8
pubmed: 11888960
Clin Microbiol Rev. 2012 Jan;25(1):106-41
pubmed: 22232373
PLoS One. 2015 Jul 06;10(7):e0130736
pubmed: 26147303
BMC Bioinformatics. 2017 Dec 06;18(1):538
pubmed: 29212440
Arch Bronconeumol (Engl Ed). 2018 Dec;54(12):625
pubmed: 30049554

Auteurs

Juan de Dios Caballero (J)

Department of Microbiology, Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute, 28034 Madrid, Spain.
CIBER of Infectious Diseases (CIBERINFEC), Institute of Health Carlos III, 28029 Madrid, Spain.

Rafael Cantón (R)

Department of Microbiology, Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute, 28034 Madrid, Spain.
CIBER of Infectious Diseases (CIBERINFEC), Institute of Health Carlos III, 28029 Madrid, Spain.

Manuel Ponce-Alonso (M)

Department of Microbiology, Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute, 28034 Madrid, Spain.
CIBER of Infectious Diseases (CIBERINFEC), Institute of Health Carlos III, 28029 Madrid, Spain.

Marta María García-Clemente (MM)

Department of Pneumology, Central Asturias University Hospital, 33011 Oviedo, Spain.
Principality Asturias Health Research Institute (ISPA), 33011 Oviedo, Spain.

Elia Gómez G de la Pedrosa (E)

Department of Microbiology, Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute, 28034 Madrid, Spain.
CIBER of Infectious Diseases (CIBERINFEC), Institute of Health Carlos III, 28029 Madrid, Spain.

José Luis López-Campos (JL)

Medical-Surgical Unit for Respiratory Diseases (CIBERES), Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, University of Seville, 41013 Sevilla, Spain.
CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.

Luis Máiz (L)

CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
Department of Pneumology, Ramón y Cajal University Hospital, 28034 Madrid, Spain.

Rosa Del Campo (R)

Department of Microbiology, Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute, 28034 Madrid, Spain.
CIBER of Infectious Diseases (CIBERINFEC), Institute of Health Carlos III, 28029 Madrid, Spain.

Miguel Ángel Martínez-García (MÁ)

CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
Department of Pneumology, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.

Classifications MeSH